Literature DB >> 2716304

Altered macrophage activity and tumor necrosis factor: tumor necrosis and host cachexia.

M C Stovroff1, D L Fraker, W D Travis, J A Norton.   

Abstract

Tumor necrosis factor (TNF) may be a mediator of cancer cachexia. This study evaluates the activity of macrophages from non-tumor-bearing (NTB) and tumor-bearing (TB) rats by measuring TNF production in response to endotoxin (LPS), both in vitro and in vivo, and correlates macrophage activity with tumor burden and parameters of host cachexia. Isolated macrophages from rats with small tumors, normal food intake, and weight gain secreted more TNF in response to 10 micrograms/ml LPS than macrophages from control NTB rats and behaved similar to activated macrophages from rats previously treated with thioglycollate. Heightened macrophage activity (increased production of TNF in response to LPS) in TB rats increased further as tumor burden increased (r = 0.889, P less than 0.001). Tumor resection reversed the heightened macrophage activity as LPS-induced levels of TNF secreted by macrophages from resected TB rats were not different from those of sham-operated NTB control rats. TB rats had serum levels of TNF activity following an iv bolus of 10 mg/kg LPS greater than those of NTB rats (P less than 0.05). In addition, peak serum TNF activity levels following iv LPS increased directly as tumor burden increased (r = 0.91, P less than 0.001). Supernatants from tissue cultures of the tumor (MCA sarcoma) failed to have any detectable TNF activity. However, large tumors in vivo had increased amounts of necrosis (78 +/- 8%), increased numbers of infiltrating macrophages, and increased levels of TNF (480 +/- 68 U/ml) compared to small tumors.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2716304     DOI: 10.1016/0022-4804(89)90161-3

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  4 in total

1.  [Significance of preoperative weight loss for perioperative metabolic adaptation and surgical risk in patients with tumors of the upper gastrointestinal tract].

Authors:  A Weimann; H J Meyer; M J Müller; P Stenkhoff; J Miholic; J Jähne; O Selberg; R Pichlmayr
Journal:  Langenbecks Arch Chir       Date:  1992

2.  The local effects of cachectin/tumor necrosis factor on wound healing.

Authors:  G D Salomon; A Kasid; D T Cromack; E Director; T L Talbot; A Sank; J A Norton
Journal:  Ann Surg       Date:  1991-08       Impact factor: 12.969

3.  Rapid turnover proteins as a prognostic indicator in cancer patients.

Authors:  Y Inoue; R Nezu; H Matsuda; Y Takagi; A Okada
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

4.  Metallothionein and zinc homeostasis during tumor progression. Effect of methotrexate treatment.

Authors:  J C Philcox; M H Tilley; P Coyle; A M Rofe
Journal:  Biol Trace Elem Res       Date:  1994-03       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.